Compare Jubilant Pharmova with IND. SWIFT - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs IND. SWIFT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT PHARMOVA IND. SWIFT JUBILANT PHARMOVA /
IND. SWIFT
 
P/E (TTM) x 13.4 -3.4 - View Chart
P/BV x 2.2 - - View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 JUBILANT PHARMOVA    IND. SWIFT
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-21
IND. SWIFT
Mar-20
JUBILANT PHARMOVA /
IND. SWIFT
5-Yr Chart
Click to enlarge
High Rs1,0476 17,622.1%   
Low Rs2512 12,251.2%   
Sales per share (Unadj.) Rs559.160.8 919.0%  
Earnings per share (Unadj.) Rs51.8-3.5 -1,466.0%  
Cash flow per share (Unadj.) Rs80.12.7 2,997.9%  
Dividends per share (Unadj.) Rs5.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs297.6-131.7 -226.0%  
Shares outstanding (eoy) m159.2854.16 294.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.20.1 1,767.5%   
Avg P/E ratio x12.5-1.1 -1,108.0%  
P/CF ratio (eoy) x8.11.5 541.8%  
Price / Book Value ratio x2.20 -7,185.6%  
Dividend payout %9.70-   
Avg Mkt Cap Rs m103,365216 47,768.7%   
No. of employees `000NANA-   
Total wages/salary Rs m21,728489 4,441.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m89,0553,295 2,702.6%  
Other income Rs m298224 133.3%   
Total revenues Rs m89,3543,519 2,539.1%   
Gross profit Rs m18,699297 6,288.2%  
Depreciation Rs m4,516336 1,344.4%   
Interest Rs m2,473352 702.8%   
Profit before tax Rs m12,008-167 -7,207.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,76425 15,300.8%   
Profit after tax Rs m8,244-191 -4,311.3%  
Gross profit margin %21.09.0 232.7%  
Effective tax rate %31.3-14.8 -212.3%   
Net profit margin %9.3-5.8 -159.5%  
BALANCE SHEET DATA
Current assets Rs m29,5252,286 1,291.3%   
Current liabilities Rs m10,4886,541 160.3%   
Net working cap to sales %21.4-129.1 -16.6%  
Current ratio x2.80.3 805.3%  
Inventory Days Days13114 10.9%  
Debtors Days Days34104 32.2%  
Net fixed assets Rs m58,1093,730 1,557.9%   
Share capital Rs m159108 146.9%   
"Free" reserves Rs m47,248-7,240 -652.6%   
Net worth Rs m47,407-7,131 -664.8%   
Long term debt Rs m25,6406,442 398.0%   
Total assets Rs m87,6346,016 1,456.6%  
Interest coverage x5.90.5 1,112.1%   
Debt to equity ratio x0.5-0.9 -59.9%  
Sales to assets ratio x1.00.5 185.5%   
Return on assets %12.22.7 457.9%  
Return on equity %17.42.7 648.5%  
Return on capital %19.8-26.9 -73.7%  
Exports to sales %069.5 0.0%   
Imports to sales %10.24.1 251.1%   
Exports (fob) Rs mNA2,290 0.0%   
Imports (cif) Rs m9,117134 6,785.5%   
Fx inflow Rs m11,2072,344 478.2%   
Fx outflow Rs m9,117187 4,887.9%   
Net fx Rs m2,0902,157 96.9%   
CASH FLOW
From Operations Rs m17,843346 5,157.4%  
From Investments Rs m-7,390-114 6,508.3%  
From Financial Activity Rs m-17,094-262 6,523.4%  
Net Cashflow Rs m-7,289-30 24,598.6%  

Share Holding

Indian Promoters % 49.7 55.6 89.4%  
Foreign collaborators % 4.4 0.0 -  
Indian inst/Mut Fund % 26.5 3.3 810.4%  
FIIs % 20.1 0.9 2,257.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 46.0 44.5 103.4%  
Shareholders   37,495 12,397 302.5%  
Pledged promoter(s) holding % 0.0 73.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT PHARMOVA With:   PIRAMAL ENTERPRISES  LASA SUPERGENERICS  DESH RAKSHAK  STRIDES PHARMA SCIENCE  KOPRAN.  



Today's Market

Sensex Trades Over 300 Points Higher, Dow Futures Up by 71 Points(12:30 pm)

Share markets in India are presently trading on a strong note.The BSE Sensex is trading up by 377 points, up 0.6%, at 62,142 levels.

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 24.0% YoY). Sales on the other hand came in at Rs 23 bn (down 2.6% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9% (Quarterly Result Update)

Oct 31, 2019 | Updated on Oct 31, 2019

For the quarter ended September 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 18.9% YoY). Sales on the other hand came in at Rs 23 bn (down 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 24.0% YoY). Sales on the other hand came in at Rs 23 bn (down 2.6% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks(Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them(Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT PHARMOVA SHARE PRICE


Oct 19, 2021 02:00 PM

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA - AUROBINDO PHARMA COMPARISON

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS